Discover Viatris

Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results

Discover Viatris

U.S. FDA Accepts Viatris Supplemental New Drug Application for Investigational Presbyopia Treatment, Sets PDUFA Goal Date

Discover Viatris

Viatris Appoints Matthew J. Maletta as Chief Legal Officer

Discover Viatris

Four Recent Regulatory Milestones Span Across All Stages of Viatris’ Global Pipeline